What is Beam Therapeutics's AOCI?

Beam Therapeutics (BEAM) reported AOCI of -$1.07M in Q1 2026.

How has Beam Therapeutics's AOCI changed year-over-year?

Beam Therapeutics's AOCI decreased by 768.8% year-over-year, from $160K to -$1.07M.

What is the long-term trend for Beam Therapeutics's AOCI?

Over 5 years (2020 to 2025), Beam Therapeutics's AOCI has grown at a 162.0% compound annual growth rate (CAGR), from -$9K to $1.11M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Beam Therapeutics BEAM AOCI

AOCI at other companies

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Arrowhead ResearchARWR

$742K-83.1%

Ultragenyx PharmaceuticalRARE

$0+100%

MGN

MagniteMGNI

-$1.48M+58.8%

CRISPR TherapeuticsCRSP

-$1.94M-147%

Intellia TherapeuticsNTLA

——

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's AOCI?: Beam Therapeutics (BEAM) reported AOCI of -$1.07M in Q1 2026.
How has Beam Therapeutics's AOCI changed year-over-year?: Beam Therapeutics's AOCI decreased by 768.8% year-over-year, from $160K to -$1.07M.
What is the long-term trend for Beam Therapeutics's AOCI?: Over 5 years (2020 to 2025), Beam Therapeutics's AOCI has grown at a 162.0% compound annual growth rate (CAGR), from -$9K to $1.11M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.